Evidence map›Paper›PMID 28861524›Full record

ArticlemSphere

Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut.

Miles W Carroll, Sam Haldenby, Natasha Y Rickett, Bernadett Pályi, Isabel Garcia-Dorival, Xuan Liu, Gary Barker, Joseph Akoi Bore, Fara Raymond Koundouno, E Diane Williamson and 16 more

Open access · goldAbstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Viral genomics in Ebola virus research.Nature reviews. Microbiology · 2020
    Review
  15. Pathogens (Basel, Switzerland) · 2020
    Article
  16. Article
  17. Article
  18. Ebola virus disease.Nature reviews. Disease primers · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 8 countries.

Miles W CarrollPublic Health England, Porton Down, Salisbury, United Kingdom.
Sam HaldenbyCentre for Genomic Research Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Natasha Y RickettInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Bernadett PályiNational Public Health Institute, National Biosafety Laboratory, Budapest, Hungary.
Isabel Garcia-DorivalInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Xuan LiuCentre for Genomic Research Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Gary BarkerSchool of Biological Sciences, University of Bristol, Bristol, United Kingdom.
Joseph Akoi BoreEuropean Mobile Laboratory, Hamburg, Germany.
Fara Raymond KoundounoEuropean Mobile Laboratory, Hamburg, Germany.
E Diane WilliamsonDefence Science Technology Laboratories, Porton Down, United Kingdom.
Thomas R LawsDefence Science Technology Laboratories, Porton Down, United Kingdom.
Romy KerberBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Daouda SissokoBordeaux Hospital University Center, INSERM U1219, Bordeaux University, Bordeaux, France.
Nóra MagyarNational Public Health Institute, National Biosafety Laboratory, Budapest, Hungary.
Antonino Di CaroEuropean Mobile Laboratory, Hamburg, Germany.
Mirella BiavaEuropean Mobile Laboratory, Hamburg, Germany.
Tom E FletcherLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Armand SprecherMédecins Sans Frontières, Brussels, Belgium.
Lisa F P NgInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Laurent RéniaSingapore Immunology Network, Agency for Science, Technology and Research, Singapore.
N'faly MagassoubaUniversité Gamal Abdel Nasser de Conakry, Laboratoire Des Fievres Hemorragiques en Guinee, Conakry, Guinea.
Stephan GüntherEuropean Mobile Laboratory, Hamburg, Germany.
Roman WölfelBundeswehr Institute of Microbiology, Munich, Germany.
Kilian StoeckerBundeswehr Institute of Microbiology, Munich, Germany.
David A MatthewsSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Julian A HiscoxInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool · GBAgency for Science, Technology and Research · SGBernhard Nocht Institute for Tropical Medicine · DEDefence Science and Technology Laboratory · GBEuropean Molecular Biology Laboratory · DENational Public Health and Medical Officer Service · HUUniversität der Bundeswehr München · DEUniversity of Bristol · GBUniversity of Liverpool · GBBordeaux Population Health · FRGamal Abdel Nasser University of Conakry · GNInstitut National de Santé Publique · GNIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITLiverpool School of Tropical Medicine · GBMédecins Sans Frontières · BESingapore Immunology Network · SG

Funding

Medical Research Council G0900753Medical Research Council MR/K002279/1
6 · The paper itself

Abstract

In this study, samples from the 2013-2016 West African Ebola virus outbreak from patients in Guinea with Ebola virus disease (EVD) were analyzed to discover and classify what other pathogens were present. Throat swabs were taken from deceased EVD patients, and peripheral blood samples were analyzed that had been taken from patients when they presented at the treatment center with acute illness. High-throughput RNA sequencing (RNA-seq) and bioinformatics were used to identify the potential microorganisms. This approach confirmed Ebola virus (EBOV) in all samples from patients diagnosed as acute positive for the virus by quantitative reverse transcription-PCR in deployed field laboratories. Nucleic acid mapping to

Indexed as

bioinformaticscoinfectionEbolaEbola virus diseasefilovirusgene expressionhost-pathogen interactionsinformaticsintracellular parasitesmalariaPlasmodium falciparumRNA-seq

Identifiers

PMID28861524
PMCPMC5566839
OpenAlexW2748558957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.